Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Coherus Oncology Inc
F:8C5
Coherus Oncology Inc
F:8C5
Price:
0.742
EUR
2.7%
Market Closed
Market Cap:
€85.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Coherus Oncology Inc
F:8C5
|
US |
|
C
|
Charter Communications Inc
F:CQD
|
US |
|
Far East Horizon Ltd
F:F6H
|
HK |
|
Agora Inc
F:9AG1
|
US |
|
C
|
China Oilfield Services Ltd
F:CO9
|
CN |
|
C
|
China Oilfield Services Ltd
XMUN:CO9
|
CN |
|
Kodiak Copper Corp
XTSX:KDK
|
CA |
|
Far East Horizon Ltd
OTC:FEZHF
|
HK |
|
R
|
Relx PLC
DUS:RDEB
|
UK |
|
I
|
International Industries Ltd
KAR:INIL
|
PK |
|
E
|
Eastern Water Resources Development and Management PCL
SET:EASTW
|
TH |
|
S
|
Standard BioTools Inc
F:FLB
|
US |
|
Shinkin Central Bank
TSE:8421
|
JP |
|
C
|
China Oilfield Services Ltd
OTC:CHOLF
|
CN |
|
S
|
Southern Cross Media Group Ltd
SWB:6MM
|
AU |
|
S
|
Southern Cross Media Group Ltd
F:6MM
|
AU |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8C5's stock price target?
Not Available
8C5 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Coherus Oncology Inc?
Projected CAGR
44%
44%
Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 44%.
What is the Gross Profit forecast for Coherus Oncology Inc?
Projected CAGR
47%
47%
The compound annual growth rate for Gross Profit over the next 7 years is 47%.
What is the Net Income forecast for Coherus Oncology Inc?
Projected CAGR
10%
10%
The compound annual growth rate for Net Income over the next 8 years is 10%.
